Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px
Document › Details

BioNTech SE. (8/7/23). "Press Release: BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update". Mainz.

Organisations Organisation BioNTech SE (Nasdaq: BNTX)
  Group BioNTech (Group)
  Organisation 2 Duality Biologics (Suzhou) Co. Ltd. (DualityBio)
Products Product antibody-drug conjugate (ADC)
  Product 2 drug development
  Index term 2 BioNTech–Duality Biologics: antibody-drug conjugates, 202304– license excl ww excl China for DB-1303 + DB-1311 $170m upfront + >$1.5b milestones + roy
Person Person Sahin, Ugur (BioNTech 201207 Managing Director BioNTech + Ribological GmbH)
     


   
Record changed: 2024-03-14

Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for BioNTech (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px




» top